Dash Bio Raises $11 Million in Latest Financing Round

Ropes & Gray, a prominent legal firm, has successfully guided Dash Bio, a preclinical and clinical bioanalysis company, in securing $11 million in its latest financing round. This funding elevates Dash Bio's total capital raised to $17.5 million. The announcement of this financing was made public on July 23 and subsequently reported in The Wall Street Journal's Venture Capital Pro. Dash Bio specializes in accelerating clinical development through its cutting-edge, technology-driven bioanalysis processes. The company employs a fully automated, GLP-compliant lab platform that integrates robotics, AI, and software to enhance the speed and quality of bioanalytical data. This advancement is crucial for biopharma teams as it aims to expedite the delivery of therapies to patients.